AU2006261048A1 - Non-steroidal progesterone receptor modulators - Google Patents

Non-steroidal progesterone receptor modulators Download PDF

Info

Publication number
AU2006261048A1
AU2006261048A1 AU2006261048A AU2006261048A AU2006261048A1 AU 2006261048 A1 AU2006261048 A1 AU 2006261048A1 AU 2006261048 A AU2006261048 A AU 2006261048A AU 2006261048 A AU2006261048 A AU 2006261048A AU 2006261048 A1 AU2006261048 A1 AU 2006261048A1
Authority
AU
Australia
Prior art keywords
rac
pct
racemic
enantiomer
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006261048A
Other languages
English (en)
Inventor
Ulrich Bothe
Peter Droescher
Ulrike Fuhrmann
Alexander Hillisch
Guenter Kaufmann
Carsten Moeller
Norbert Schmees
Anja Schmidt
Wolfgang Schwede
Lothar Sobek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of AU2006261048A1 publication Critical patent/AU2006261048A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2006261048A 2005-06-24 2006-06-22 Non-steroidal progesterone receptor modulators Abandoned AU2006261048A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102005030292.0 2005-06-24
PCT/EP2006/006531 WO2006136461A2 (en) 2005-06-24 2006-06-22 Non-steroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
AU2006261048A1 true AU2006261048A1 (en) 2006-12-28

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006261048A Abandoned AU2006261048A1 (en) 2005-06-24 2006-06-22 Non-steroidal progesterone receptor modulators

Country Status (22)

Country Link
EP (1) EP1902049A2 (pt)
JP (1) JP2008543910A (pt)
KR (1) KR20080030622A (pt)
CN (1) CN101248066A (pt)
AR (1) AR054519A1 (pt)
AU (1) AU2006261048A1 (pt)
BR (1) BRPI0611903A2 (pt)
CA (1) CA2611897A1 (pt)
CR (1) CR9598A (pt)
DE (1) DE102005030292A1 (pt)
DO (1) DOP2006000148A (pt)
EA (1) EA200702524A1 (pt)
EC (1) ECSP078044A (pt)
GT (1) GT200600271A (pt)
IL (1) IL188021A0 (pt)
MX (1) MX2008000072A (pt)
NO (1) NO20080440L (pt)
PE (1) PE20070125A1 (pt)
TW (1) TW200740778A (pt)
UY (1) UY29624A1 (pt)
WO (1) WO2006136461A2 (pt)
ZA (1) ZA200800690B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
WO2010002075A1 (en) * 2008-07-02 2010-01-07 Pharmacostech Co., Ltd. Methods for preparing amide derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
BRPI0412231A (pt) * 2003-07-01 2006-08-22 Schering Ag derivados de pentanol substituìdos heterociclicamente, processos para a sua preparação e sua aplicação como inibidores de inflamação

Also Published As

Publication number Publication date
BRPI0611903A2 (pt) 2010-10-05
CA2611897A1 (en) 2006-12-28
PE20070125A1 (es) 2007-02-14
KR20080030622A (ko) 2008-04-04
CR9598A (es) 2008-04-09
UY29624A1 (es) 2007-01-31
TW200740778A (en) 2007-11-01
JP2008543910A (ja) 2008-12-04
MX2008000072A (es) 2008-03-24
AR054519A1 (es) 2007-06-27
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
NO20080440L (no) 2008-03-25
DE102005030292A1 (de) 2007-01-11
IL188021A0 (en) 2008-03-20
ZA200800690B (en) 2009-09-30
EA200702524A1 (ru) 2008-06-30
ECSP078044A (es) 2008-01-23
EP1902049A2 (en) 2008-03-26
CN101248066A (zh) 2008-08-20
DOP2006000148A (es) 2007-07-15
GT200600271A (es) 2007-02-05

Similar Documents

Publication Publication Date Title
EP3312184A1 (en) Piperidine derivative and preparation method and pharmaceutical use thereof
EA005926B1 (ru) Нестероидные ингибиторы воспалений
WO2014036897A1 (zh) 咪唑啉类衍生物、其制备方法及其在医药上的应用
EP1999111A2 (en) Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
US20040198980A1 (en) Selective rxr ligands
TW200934487A (en) TRPV1 antagonists
JP7401576B2 (ja) 15β-[3-プロパンアミド]-置換エストラ-1,3,5(10)-トリエン-17-オン化合物および17β-ヒドロキシステロイドデヒドロゲナ-ゼの阻害に使用するためのそれらの17-オキシム
AU2006261048A1 (en) Non-steroidal progesterone receptor modulators
WO2009012954A1 (en) Novel estrogen receptor ligands
CA2611900A1 (en) Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
US7071205B2 (en) 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
US20040152717A1 (en) 5-Substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
US20070010514A1 (en) Non-steroidal progesterone receptor modulators
US7408060B2 (en) Nonsteroidal progesterone receptor modulators
US20080188448A1 (en) Non-steroidal progesterone receptor modulators
US20090099147A1 (en) Non-steroidal progesterone receptor modulators
WO2008077646A1 (de) Nichtsteroidale progesteronrezeptor-modulatoren
TW200835498A (en) Non-steroidal progesterone receptor modulators
EP2070909A1 (de) Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007049630A1 (de) Nichtsteroidale Progesteronrezeptor-Modulatoren
WO2009007396A1 (de) Nichtsteroidale progesteronrezeptor-modulatoren

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period